AUTHOR=Vetrugno Luigi , Sala Alessia , Orso Daniele , Meroi Francesco , Fabbro Sebastiano , Boero Enrico , Valent Francesca , Cammarota Gianmaria , Restaino Stefano , Vizzielli Giuseppe , Girometti Rossano , Merelli Maria , Tascini Carlo , Bove Tiziana , Driul Lorenza , The PINK-CO study investigators , Mattuzzi Lisa , Marin Matteo , D'Andrea Natascia , Zanini Victor , Divella Michele , Occhiali Tommaso , Barbui Elisa , Codutti Enrica , Fosca Elisa , Nanino Michela , Scaiella Giuliana , Berchialla Paola TITLE=Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study JOURNAL=Frontiers in Medicine VOLUME=8 YEAR=2022 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.768261 DOI=10.3389/fmed.2021.768261 ISSN=2296-858X ABSTRACT=Objective

To analyze the application of lung ultrasound (LUS) diagnostic approach in obstetric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and compare LUS score and symptoms of the patients.

Design

A single-center observational retrospective study from October 31, 2020 to March 31, 2021.

Setting

Department of Ob/Gyn at the University-Hospital of Udine, Italy.

Participants

Pregnant women with SARS-CoV-2 diagnosed with reverse transcription-PCR (RT-PCR) swab test were subdivided as symptomatic and asymptomatic patients with COVID-19.

Exposure

Lung ultrasound evaluation both through initial evaluation upon admission and through serial evaluations.

Main Outcome

Reporting LUS findings and LUS score characteristics.

Results

Symptomatic patients with COVID-19 showed a higher LUS (median 3.5 vs. 0, p < 0.001). LUS was significantly correlated with COVID-19 biomarkers as C-reactive protein (CPR; p = 0.011), interleukin-6 (p = 0.013), and pro-adrenomedullin (p = 0.02), and inversely related to arterial oxygen saturation (p = 0.004). The most frequent ultrasound findings were focal B lines (14 vs. 2) and the light beam (9 vs. 0).

Conclusion

Lung ultrasound can help to manage pregnant women with SARS-CoV-2 infection during a pandemic surge.

Study Registration

ClinicalTrials.gov, NCT04823234. Registered on March 29, 2021.